FENIMORE CHRISTOPHER R. (VP Controller) exercised options at REGENERON PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 8/20/2026ACC: 0001697422-26-000002
Officer· VP Controller
Since Aug 2018
-4.60K
Net shares
Net seller
$3.74M
Total sold
0
Open market trades
0B · 0S
3
Total transactions
6.28K acquired · 10.88K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+6.28K
Price / share
$381.92
Trade value
$2.40M
% of position
34.3%
8/18/2026
18.30K→24.58K
Common Stock
Direct
Shares
−4.60K
Price / share
$813.47
Trade value
$3.74M
% of position
18.7%
8/18/2026
24.58K→19.98K
Total
Net shares
+1.68K
Net value
-$1.34M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/18/2026 | M · Option Exercise | +6.28K | $381.92 | $2.40M | 34.3% | 18.30K | 24.58K |
| Common Stock Direct | 8/18/2026 | F · Tax Withholding | −4.60K | $813.47 | $3.74M | 18.7% | 24.58K | 19.98K |
| Total | +1.68K | -$1.34M | ||||||
Derivative Transactions1
Non-Qualified Stock Option (right to buy)
Direct
Converts to
Common Stock
6.28K shares
Shares
−6.28K
Strike price
381.92
Held after
6K
Exercisable
—
8/18/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock6.28K shares | 8/18/2026 | M · Option Exercise | −6.28K | 381.92 | — | 6K |
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned1.57K
Common Stock
IndirectShares owned1.90K
Common Stock
IndirectShares owned25.00
Common Stock
IndirectShares owned25.00
Total
3.52K indirect3.52K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.57K | Indirect |
| Common Stock | 1.90K | Indirect |
| Common Stock | 25.00 | Indirect |
| Common Stock | 25.00 | Indirect |
| Total | 3.52K | 3.52K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported